AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
- DOI
- 10.1038/s41698-023-00360-5
- Published
- 2023-02-16
- Container
- npj Precision Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-023-00360-5,
title = {AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers},
author = {Maysa M. Abu-Khalaf and K. Alex Hodge and Christos Hatzis and Elisa Baldelli and Emna El Gazzah and Frances Valdes and William M. Sikov and Monica M. Mita and Neelima Denduluri and Rita Murphy and Daniel Zelterman and Lance Liotta and Bryant Dunetz and Rick Dunetz and Emanuel F. Petricoin and Mariaelena Pierobon},
year = {2023},
journal = {npj Precision Oncology},
doi = {10.1038/s41698-023-00360-5},
url = {https://doi.org/10.1038/s41698-023-00360-5}
}RIS
TY - JOUR TI - AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers AU - Maysa M. Abu-Khalaf AU - K. Alex Hodge AU - Christos Hatzis AU - Elisa Baldelli AU - Emna El Gazzah AU - Frances Valdes AU - William M. Sikov AU - Monica M. Mita AU - Neelima Denduluri AU - Rita Murphy AU - Daniel Zelterman AU - Lance Liotta AU - Bryant Dunetz AU - Rick Dunetz AU - Emanuel F. Petricoin AU - Mariaelena Pierobon PY - 2023 JO - npj Precision Oncology DO - 10.1038/s41698-023-00360-5 UR - https://doi.org/10.1038/s41698-023-00360-5 ER -
APA
Abu-Khalaf, M. M., Hodge, K. A., Hatzis, C., Baldelli, E., Gazzah, E. E., Valdes, F., Sikov, W. M., Mita, M. M., Denduluri, N., Murphy, R., Zelterman, D., Liotta, L., Dunetz, B., Dunetz, R., Petricoin, E. F., & Pierobon, M. (2023). AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers. npj Precision Oncology. https://doi.org/10.1038/s41698-023-00360-5
Source records
- crossref · retrieved 2026-09-26T07:13:44.007Z